APA (7th ed.) Citation

Plæhn, G., Fuglsang, T., Hindersson, P., & Breindahl, T. (2024). Adverse effects from counterfeit and mislabeled medicine containing tapentadol and carisoprodol. Clinical Case Reports, 12(8), 1. https://doi.org/10.1002/ccr3.9241

Chicago Style (17th ed.) Citation

Plæhn, Gitte, Thomas Fuglsang, Peter Hindersson, and Torben Breindahl. "Adverse Effects from Counterfeit and Mislabeled Medicine Containing Tapentadol and Carisoprodol." Clinical Case Reports 12, no. 8 (2024): 1. https://doi.org/10.1002/ccr3.9241.

MLA (9th ed.) Citation

Plæhn, Gitte, et al. "Adverse Effects from Counterfeit and Mislabeled Medicine Containing Tapentadol and Carisoprodol." Clinical Case Reports, vol. 12, no. 8, 2024, p. 1, https://doi.org/10.1002/ccr3.9241.